Oberweis Asset Management Inc. Makes New $14.14 Million Investment in Dolby Laboratories, Inc. (NYSE:DLB)

Oberweis Asset Management Inc. purchased a new stake in Dolby Laboratories, Inc. (NYSE:DLB - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 181,000 shares of the electronics maker's stock, valued at approximately $14,136,000. Oberweis Asset Management Inc. owned approximately 0.19% of Dolby Laboratories as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Lord Abbett & CO. LLC grew its position in Dolby Laboratories by 5.8% in the third quarter. Lord Abbett & CO. LLC now owns 284,466 shares of the electronics maker's stock worth $21,771,000 after acquiring an additional 15,546 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in shares of Dolby Laboratories by 10,441,900.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 104,420 shares of the electronics maker's stock valued at $8,123,000 after purchasing an additional 104,419 shares during the last quarter. Barclays PLC boosted its holdings in Dolby Laboratories by 80.5% in the third quarter. Barclays PLC now owns 33,230 shares of the electronics maker's stock worth $2,544,000 after purchasing an additional 14,825 shares in the last quarter. Franklin Resources Inc. increased its position in Dolby Laboratories by 22.0% during the third quarter. Franklin Resources Inc. now owns 47,247 shares of the electronics maker's stock worth $3,513,000 after buying an additional 8,509 shares during the last quarter. Finally, AlphaQuest LLC raised its holdings in Dolby Laboratories by 111.1% during the fourth quarter. AlphaQuest LLC now owns 6,148 shares of the electronics maker's stock valued at $480,000 after buying an additional 3,235 shares in the last quarter. Institutional investors and hedge funds own 58.56% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on DLB shares. Rosenblatt Securities reiterated a "buy" rating and set a $100.00 price target on shares of Dolby Laboratories in a research note on Thursday, January 30th. StockNews.com cut Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a research report on Friday, January 31st. Finally, Barrington Research reissued an "outperform" rating and issued a $100.00 price target on shares of Dolby Laboratories in a research report on Thursday, February 13th.

Dolby Laboratories Stock Up 0.3 %

NYSE DLB traded up $0.21 during trading on Monday, hitting $75.96. The company's stock had a trading volume of 322,632 shares, compared to its average volume of 453,339. Dolby Laboratories, Inc. has a 52 week low of $66.35 and a 52 week high of $89.66. The firm has a market cap of $7.25 billion, a P/E ratio of 27.93 and a beta of 0.94. The firm has a 50 day moving average price of $78.32 and a 200 day moving average price of $78.30.

Dolby Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, February 19th. Investors of record on Tuesday, February 11th were paid a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 1.74%. The ex-dividend date was Tuesday, February 11th. Dolby Laboratories's payout ratio is currently 48.53%.

Insider Buying and Selling at Dolby Laboratories

In related news, EVP Mark Andrew Sherman sold 40,000 shares of Dolby Laboratories stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $84.88, for a total transaction of $3,395,200.00. Following the sale, the executive vice president now directly owns 62,397 shares of the company's stock, valued at $5,296,257.36. This trade represents a 39.06 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CMO Todd Pendleton sold 18,121 shares of the firm's stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $83.75, for a total value of $1,517,633.75. Following the completion of the sale, the chief marketing officer now owns 37,290 shares of the company's stock, valued at $3,123,037.50. This represents a 32.70 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 65,121 shares of company stock valued at $5,501,324 in the last ninety days. Company insiders own 38.39% of the company's stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.